STW204

N/A

Report date: 2025/03/27 20:00:06

Base Information

Drug NameSTW204
Drug Alias NameARMOZX阿沐珠人源化单抗hAB21STW204 单抗注射液STW-204AI025 +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPending
Originator CompaniesSuzhou Stainwei Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcroImmune Group
Inactive CompaniesSuzhou Stainwei Biotech Inc
Active IndicationsNeoplasms
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A